News & Perspective
Drugs & Diseases
CME & Education
Academy
Video
Decision Point
Edition: English

Medscape

English
Deutsch
Español
Français
Português
UKNew

Univadis

Sign Up It's Free!
English Edition

Medscape

Univadis

    X
    Univadis from Medscape

    No Results

      News & Perspective Drugs & Diseases CME & Education Academy Video Decision Point
      Drugs & Diseases > Obstetrics & Gynecology

      Macrosomia Follow-up

      Updated: Dec 16, 2020
      • Author: Easha A Patel, MD; Chief Editor: Christine Isaacs, MD  more...
      • Print
      Follow-up

      Further Outpatient Care

      Diabetes is the major risk associated with macrosomia, and this risk is for both the mother and the neonate. Once a mother gives birth to a macrosomic child, early maternal glucose screening should be considered in subsequent pregnancies.

      The macrosomic infant may be at risk of developing diabetes and obesity later in life and deserves careful long-term follow-up care. This risk of developing a metabolic syndrome in adolescents was recently addressed by Boney et al in a study of appropriate for gestational age (AGA) and large for gestational age (LGA) infants of women with normal glucose tolerance and gestational diabetes mellitus (GDM). [70] Metabolic syndrome was defined as two or more of the following being present: obesity, hypertension, glucose intolerance, and dyslipidemia. Children who were LGA at birth had an increased risk of metabolic syndrome (2.19, 95% CI, 1.25–3.82, P=.01) by 11 years of age, as did children of obese women (1.81, 95% CI, 1.03–3.19, P=.04). The presence of maternal GDM was not independently significant, but the risk of metabolic syndrome was significantly different between LGA and AGA children of women with GDM by age 11 (relative risk 3.6).

      Next:

      Deterrence/Prevention

      Several potentially useful strategies may be helpful in prevention of macrosomia. Note the following:

      • In both diabetic mothers and in those with gestational diabetes, tight control during pregnancy with the use of diet and insulin can reduce the frequency of macrosomia. The association between post-meal glucose levels and fetal macrosomia has been studied and illustrated. [71]

      • Prevention of maternal obesity before pregnancy may reduce the frequency of macrosomia. However, no clinical randomized trials have validated this hypothesis. Obesity is also associated with other morbidities in pregnancy, including higher rates of preeclampsia and cesarean delivery.

      • Maggard et al published data on pregnancy outcome from obese women after bariatric surgery. These results showed improvements in pregnancy outcome, including macrosomia, which was reduced by almost 50%. [72] These findings were confirmed by Karmon et al, indicating a reduction in maternal morbidity related to obesity after bariatric surgery. [73]  The rate of LGA infants was decreased in those who had bariatric surgery in a large study that included 627,693 women with a history of bariatric surgery from the Swedish birth registry. The risk of gestational diabetes was also reduced. However, the rate of small for gestational age (SGA) infants was also higher in this group. The risk of preterm birth was not different. [74]  Nonetheless, ACOG recommends counseling patients with class 2 or class 3 obesity regarding the risks and benefits of bariatric surgery prior to pregnancy. [1]

      Previous
      Next:

      Patient Education

      As with obesity, excessive maternal weight gain can be prevented by appropriate education of expecting mothers regarding weight gain in pregnancy. Such interventions may reduce the risk of macrosomia in specific pregnancies that may have been placed at risk because of excessive maternal weight gain. However, although excessive maternal weight or weight gain in pregnancy has been associated with fetal macrosomia, the effectiveness of reducing prepregnancy weight or curtailing excessive weight gain in pregnancy has not been tested to determine whether these measures will reduce rates of fetal macrosomia. Furthermore, one must consider the risk of insufficient gestational weight gain including increased risk of growth restriction. [75]

      For patient education resources, see Pregnancy Center, as well as Pregnancy.

      Previous
       
      Media Gallery
      of 1
      Find Us On
      About
      About Medscape Privacy Policy Editorial Policy Cookies Terms of Use Advertising Policy Help Center
      Membership
      Become a Member About You Professional Information Newsletters & Alerts Market Research
      App
      Medscape
      WebMD Network
      Medscape Live Events WebMD MedicineNet eMedicineHealth RxList WebMD Corporate Medscape UK
      Editions
      English Deutsch Español Français Português UK
      All material on this website is protected by copyright, Copyright © 1994-2022 by WebMD LLC. This website also contains material copyrighted by 3rd parties.